JP2023025005A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023025005A5 JP2023025005A5 JP2022178566A JP2022178566A JP2023025005A5 JP 2023025005 A5 JP2023025005 A5 JP 2023025005A5 JP 2022178566 A JP2022178566 A JP 2022178566A JP 2022178566 A JP2022178566 A JP 2022178566A JP 2023025005 A5 JP2023025005 A5 JP 2023025005A5
- Authority
- JP
- Japan
- Prior art keywords
- vector
- virus
- vectors
- phage
- viral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000013598 vector Substances 0.000 claims description 35
- 239000013603 viral vector Substances 0.000 claims description 5
- 241000710929 Alphavirus Species 0.000 claims description 3
- 241000702421 Dependoparvovirus Species 0.000 claims description 3
- 241000712079 Measles morbillivirus Species 0.000 claims description 3
- 241000711975 Vesicular stomatitis virus Species 0.000 claims description 3
- 241000701161 unidentified adenovirus Species 0.000 claims description 3
- 241001529453 unidentified herpesvirus Species 0.000 claims description 3
- 241000713666 Lentivirus Species 0.000 claims description 2
- 241001430294 unidentified retrovirus Species 0.000 claims description 2
- 241000701959 Escherichia virus Lambda Species 0.000 claims 1
- 241000724791 Filamentous phage Species 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 230000033115 angiogenesis Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 230000001177 retroviral effect Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025092726A JP2025143268A (ja) | 2013-01-17 | 2025-06-03 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13151593 | 2013-01-17 | ||
| EP13151593.4 | 2013-01-17 | ||
| JP2020135954A JP7685737B2 (ja) | 2013-01-17 | 2020-08-11 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020135954A Division JP7685737B2 (ja) | 2013-01-17 | 2020-08-11 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025092726A Division JP2025143268A (ja) | 2013-01-17 | 2025-06-03 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023025005A JP2023025005A (ja) | 2023-02-21 |
| JP2023025005A5 true JP2023025005A5 (cg-RX-API-DMAC7.html) | 2024-10-31 |
Family
ID=47559322
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015553072A Active JP6809789B2 (ja) | 2013-01-17 | 2014-01-16 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
| JP2020135954A Active JP7685737B2 (ja) | 2013-01-17 | 2020-08-11 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
| JP2022178566A Pending JP2023025005A (ja) | 2013-01-17 | 2022-11-08 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
| JP2025092726A Pending JP2025143268A (ja) | 2013-01-17 | 2025-06-03 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015553072A Active JP6809789B2 (ja) | 2013-01-17 | 2014-01-16 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
| JP2020135954A Active JP7685737B2 (ja) | 2013-01-17 | 2020-08-11 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025092726A Pending JP2025143268A (ja) | 2013-01-17 | 2025-06-03 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10369198B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3747457A3 (cg-RX-API-DMAC7.html) |
| JP (4) | JP6809789B2 (cg-RX-API-DMAC7.html) |
| CN (6) | CN111100197B (cg-RX-API-DMAC7.html) |
| CA (1) | CA2898128A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2945642T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2986021T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI2945642T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20240623T1 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE068364T2 (cg-RX-API-DMAC7.html) |
| LT (1) | LT2945642T (cg-RX-API-DMAC7.html) |
| PL (1) | PL2945642T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2945642T (cg-RX-API-DMAC7.html) |
| RS (1) | RS65553B1 (cg-RX-API-DMAC7.html) |
| SI (1) | SI2945642T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014111458A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111100197B (zh) * | 2013-01-17 | 2024-11-15 | 汉诺威医学院 | 用于治疗或预防疾病的因子1蛋白、因子2蛋白及其抑制剂 |
| EP4005585B1 (en) | 2013-11-21 | 2024-03-27 | The Brigham & Women's Hospital, Inc. | Compositions and methods for treating right ventricular hypertrophy |
| EP3174550B1 (en) * | 2014-08-01 | 2020-01-29 | The Brigham and Women's Hospital, Inc. | Methods and compositions relating to treatment of pulmonary arterial hypertension |
| US10435757B1 (en) | 2016-06-15 | 2019-10-08 | University Of South Florida | Methods of measuring C19MC miRNA in a post-natal tissue and uses thereof |
| CN108802372B (zh) * | 2018-06-19 | 2021-05-11 | 上海伦泽生物科技有限公司 | 检测人血清中内质网膜蛋白复合体亚单位10的试剂盒 |
| AU2021211874A1 (en) | 2020-01-21 | 2022-08-25 | Boehringer Ingelheim International Gmbh | Myeloid-derived growth factor for use in treating or preventing fibrosis, hypertrophy or heart failure |
| CN114149499B (zh) * | 2020-09-07 | 2023-12-05 | 复旦大学附属华山医院 | 抗人emc10的单克隆抗体及其在治疗和/或预防肥胖症中的应用 |
| CN114149498B (zh) * | 2020-09-07 | 2023-12-05 | 复旦大学附属华山医院 | 抗人emc10的单克隆抗体在防治2型糖尿病中的应用 |
| CN114149500B (zh) * | 2020-09-07 | 2023-12-01 | 复旦大学附属华山医院 | 抗人emc10的单克隆抗体在制备治疗和/或预防脂肪肝的产品中的应用 |
| AU2021405790A1 (en) | 2020-12-23 | 2023-07-06 | Boehringer Ingelheim International Gmbh | Viral capsid proteins with specificity to heart tissue cells |
| WO2023283649A1 (en) * | 2021-07-08 | 2023-01-12 | Tenaya Therapeutics, Inc. | Optimized expression cassettes for gene therapy |
| US20250333459A1 (en) | 2022-06-03 | 2025-10-30 | Boehringer Ingelheim International Gmbh | Recombinant expression of myeloid-derived growth factor |
| WO2024052564A1 (en) | 2022-09-08 | 2024-03-14 | Boehringer Ingelheim International Gmbh | Myeloid-derived growth factor for use in treating cardiogenic shock |
| WO2025047991A1 (en) | 2023-09-01 | 2025-03-06 | Boehringer Ingelheim International Gmbh | Myeloid-derived growth factor for use in treating or preventing a liver disorder |
| WO2025073372A1 (en) | 2023-10-05 | 2025-04-10 | Boehringer Ingelheim International Gmbh | Recombinant expression of myeloid-derived growth factor |
| WO2025120204A1 (en) | 2023-12-06 | 2025-06-12 | Boehringer Ingelheim International Gmbh | Novel formulation comprising myeloid-derived growth factor |
| CN120738287A (zh) * | 2025-07-03 | 2025-10-03 | 广州医科大学附属妇女儿童医疗中心 | 急性低灌注动物模型的构建方法及其应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3584341D1 (de) | 1984-08-24 | 1991-11-14 | Upjohn Co | Rekombinante dna-verbindungen und expression von polypeptiden wie tpa. |
| JP2002500502A (ja) | 1996-06-11 | 2002-01-08 | メルク エンド カンパニー インコーポレーテッド | 合成ｃ型肝炎遺伝子 |
| EP0932676A2 (en) * | 1996-09-13 | 1999-08-04 | Sagami Chemical Research Center | HUMAN PROTEINS HAVING SECRETORY SIGNAL SEQUENCES AND DNAs ENCODING THESE PROTEINS |
| JP2001506484A (ja) * | 1996-09-13 | 2001-05-22 | 財団法人相模中央化学研究所 | 分泌シグナル配列を有するヒト蛋白質およびそれをコードするｄｎａ |
| DE69827021T2 (de) * | 1997-01-29 | 2005-02-24 | Cornell Research Foundation, Inc. | An verschiedenen orten verabreichung von adenoviren-vektor zur induzierung von angiogenese |
| CA2374180C (en) | 1999-05-26 | 2012-09-11 | Marita Hiipakka | Methods and materials for generating sh3 domains with tailored binding properties |
| DE60038740T2 (de) * | 1999-06-02 | 2009-07-02 | Genentech, Inc., South San Francisco | Stimulierung oder hemmung von angiogenese und herzvaskularisierung |
| CA2381985A1 (en) * | 1999-08-16 | 2001-02-22 | Universita'degli Studi Di Siena | Vegf-d and angiogenic use thereof |
| CA2416538A1 (en) * | 2000-07-20 | 2002-01-31 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| WO2002081681A1 (fr) * | 2001-03-30 | 2002-10-17 | Chugai Seiyaku Kabushiki Kaisha | Nouvelle utilisation de la cytokine sf20 |
| DE10119804A1 (de) * | 2001-04-23 | 2002-10-24 | Brahms Ag | Entzündungsspezifische Peptide und deren Verwendungen |
| US7452968B2 (en) | 2003-01-02 | 2008-11-18 | University Of Southern California | Secreted protein factor and cell membrane-bound splice variant |
| WO2004069173A2 (en) * | 2003-01-31 | 2004-08-19 | The Trustees Of The University Of Pennsylvania | Methods for modulating an inflammatory response |
| US8486438B2 (en) | 2004-01-29 | 2013-07-16 | Brown University | Methods for progenitor cell recruitment and isolation |
| CN101160055A (zh) * | 2005-02-16 | 2008-04-09 | 莱蒂恩公司 | 慢病毒载体及其用途 |
| US20080004232A1 (en) * | 2006-05-09 | 2008-01-03 | John Wilkins | Characterization of c19orf10, a Novel Synovial Protein |
| EP1892248A1 (en) | 2006-08-21 | 2008-02-27 | Eidgenössische Technische Hochschule Zürich | Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase |
| EP2130547A1 (en) * | 2008-06-06 | 2009-12-09 | Giuliani International Limited | IL-25 for use in the treatment of inflammatory diseases |
| CN102741288B (zh) * | 2009-08-29 | 2015-08-19 | Abbvie公司 | 治疗用dll4结合蛋白 |
| US8735342B2 (en) | 2010-01-27 | 2014-05-27 | Neumedicines, Inc. | Method for treating brain cancer using a novel tumor suppressor gene and secreted factor |
| KR20120095063A (ko) * | 2011-02-18 | 2012-08-28 | 가톨릭대학교 산학협력단 | ＩＬ-27로 유도된 ｐ53을 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 |
| CN111100197B (zh) * | 2013-01-17 | 2024-11-15 | 汉诺威医学院 | 用于治疗或预防疾病的因子1蛋白、因子2蛋白及其抑制剂 |
-
2014
- 2014-01-16 CN CN201911137853.9A patent/CN111100197B/zh active Active
- 2014-01-16 LT LTEPPCT/EP2014/050788T patent/LT2945642T/lt unknown
- 2014-01-16 US US14/759,852 patent/US10369198B2/en active Active
- 2014-01-16 CN CN201911137855.8A patent/CN110903378A/zh active Pending
- 2014-01-16 HU HUE14700872A patent/HUE068364T2/hu unknown
- 2014-01-16 EP EP20178045.9A patent/EP3747457A3/en active Pending
- 2014-01-16 CA CA2898128A patent/CA2898128A1/en active Pending
- 2014-01-16 FI FIEP14700872.6T patent/FI2945642T3/fi active
- 2014-01-16 CN CN201911137854.3A patent/CN110922468B/zh active Active
- 2014-01-16 EP EP14700872.6A patent/EP2945642B1/en active Active
- 2014-01-16 CN CN201911138039.9A patent/CN110922467A/zh active Pending
- 2014-01-16 DK DK14700872.6T patent/DK2945642T3/da active
- 2014-01-16 CN CN201911124174.8A patent/CN110894226A/zh active Pending
- 2014-01-16 PL PL14700872.6T patent/PL2945642T3/pl unknown
- 2014-01-16 WO PCT/EP2014/050788 patent/WO2014111458A2/en not_active Ceased
- 2014-01-16 RS RS20240548A patent/RS65553B1/sr unknown
- 2014-01-16 ES ES14700872T patent/ES2986021T3/es active Active
- 2014-01-16 HR HRP20240623TT patent/HRP20240623T1/hr unknown
- 2014-01-16 SI SI201432073T patent/SI2945642T1/sl unknown
- 2014-01-16 PT PT147008726T patent/PT2945642T/pt unknown
- 2014-01-16 JP JP2015553072A patent/JP6809789B2/ja active Active
- 2014-01-16 CN CN201480005079.5A patent/CN104968361B/zh active Active
-
2020
- 2020-08-11 JP JP2020135954A patent/JP7685737B2/ja active Active
-
2022
- 2022-11-08 JP JP2022178566A patent/JP2023025005A/ja active Pending
-
2025
- 2025-06-03 JP JP2025092726A patent/JP2025143268A/ja active Pending